全膝关节置换术前减重策略的短期并发症:减重手术与胰高血糖素样肽-1受体激动剂的比较
该回顾性研究基于国家研究网络2005年5月1日至2025年2月12日的数据,经倾向评分匹配后比较了全膝关节置换术前18个月内接受减重手术或胰高血糖素样肽-1受体激动剂(GLP-1 RA)处方的各4652例患者。结果显示减重手术组90天内假体周围骨折、假体周围关节感染、翻修手术、心脏事件、再入院和急诊就诊的风险均高于GLP-1 RA组。作者认为GLP-1 RA可能是全膝关节置换术前减重优化的优选方案。
要点
- 减重手术组假体周围骨折风险为GLP-1 RA组的2.4倍(RR 2.4,P=0.016)。
- 减重手术组假体周围关节感染风险为GLP-1 RA组的1.7倍(RR 1.7,P=0.002)。
- 减重手术组翻修手术风险为GLP-1 RA组的1.926倍(RR 1.926,P=0.005)。
核心结论
- 减重手术组患者术后事件风险显著增加,结合现有文献,作者认为GLP-1 RA可能是全膝关节置换术前减重优化的优选方案。
研究设计与样本
- 回顾性研究,基于国家研究网络2005年5月1日至2025年2月12日的数据,纳入全膝关节置换术前18个月内接受减重手术或GLP-1 RA处方的患者。
- 经倾向评分匹配后,减重手术组和GLP-1 RA组各4652例患者纳入比较。
- 收集患者人口学特征、90天骨科和手术并发症、再入院及急诊就诊情况,采用t检验和卡方检验计算相对风险(RR)的统计学差异。
主要发现
- 减重手术组相比GLP-1 RA组,假体周围骨折风险升高(RR 2.4,P=0.016)。
- 减重手术组相比GLP-1 RA组,假体周围关节感染风险升高(RR 1.7,P=0.002)。
- 减重手术组相比GLP-1 RA组,翻修手术风险升高(RR 1.926,P=0.005)。
- 减重手术组相比GLP-1 RA组,心脏事件风险升高(RR 1.255,P<0.001)。
- 减重手术组相比GLP-1 RA组,再入院风险升高(RR 1.316,P=0.015),急诊就诊风险升高(RR 1.2,P<0.001)。
临床怎么用
- 作者认为,结合现有文献,GLP-1 RA使用可能是全膝关节置换术前减重优化的优选方案。
- 作者指出,这些发现增进了对该药物的临床理解,并可能为关于体重管理策略及其相关风险的手术决策提供参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is an increasingly prevalent comorbidity that confers greater risks of postoperative complications following total joint arthroplasty, underscoring the need for viable preoperative weight loss. The objective of this study was to compare the risk of 90-day adverse events in patients undergoing total knee arthroplasty (TKA) following bariatric surgery versus treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RA). METHODS: A retrospective review of a national research network from May 1, 2005, to February 12, 2025, identified patients undergoing TKA with bariatric surgery or GLP-1 RA prescriptions in the 18 months preceding their joint arthroplasty. Following propensity score matching, 4,652 patients were selected for comparison in both the bariatric surgery and GLP-1 RA cohorts. For each cohort, patient demographics, 90-day orthopaedic and surgical complications, readmissions, and emergency department visits were collected. Statistical differences in relative risk (RR) between each complication were calculated with t-tests and Chi-square tests. RESULTS: In the 90-day postoperative period, patients who underwent bariatric surgery before TKA experienced greater rates of periprosthetic fractures (RR: 2.4; P = 0.016), periprosthetic joint infections (RR: 1.7; P = 0.002), revision surgeries (RR: 1.926; P = 0.005), cardiac events (RR: 1.255; P < 0.001), readmissions (RR: 1.316; P = 0.015), and emergency department visits (RR: 1.2; P < 0.001). CONCLUSIONS: A significantly increased risk of postoperative events was identified in patients who underwent bariatric surgery. These findings, along with existing literature, suggest that GLP-1 RA use may be a preferred option for preoperative weight loss optimization in TKAs. Overall, greater clinical understanding is provided for this drug and may inform surgical decision-making regarding weight management strategies and their associated risks.
引用
- Sharma A, Lieu BA, Velichala SR, et al. Short-Term Complications of Preoperative Weight Loss Strategies in Total Knee Arthroplasty: Bariatric Surgery Versus Glucagon-Like Peptide-1 Receptor Agonists. J Arthroplasty. 2025. PMID: 40912337. doi:10.1016/j.arth.2025.08.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。